Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BioInvent International AB | 442,880 | net | 24 Apr 2018 | tx 8+442,880 |
| Bio-Works Technologies AB | 234,713 | net | 01 Apr 2022 | tx 2+234,713 |
| Medivir AB | -29,248 | net | 17 Feb 2017 | tx 2+13,000−42,248 |
| CellaVision AB | 7,000 | net | 20 Jul 2017 | tx 1+7,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Apr 2022 | OTHER | Bio-Works Technologies AB | 171,749 | 0.00 SEK | deriv |
| 01 Apr 2022 | PURCHASE | Bio-Works Technologies AB | 62,964 | 0.57 SEK | first after silence |
| 24 Apr 2018 | PURCHASE | BioInvent International AB | 55,360 | 0.00 SEK | |
| 24 Apr 2018 | OTHER | BioInvent International AB | 55,360 | 0.08 SEK | |
| 24 Apr 2018 | PURCHASE | BioInvent International AB | 55,360 | 0.00 SEK | |
| 24 Apr 2018 | OTHER | BioInvent International AB | 55,360 | 0.08 SEK | |
| 20 Jul 2017 | PURCHASE | CellaVision AB | 7,000 | 133.25 SEK | |
| 17 Feb 2017 | PURCHASE | Medivir AB | 13,000 | 77.77 SEK | |
| 17 Feb 2017 | SALE | Medivir AB | 42,248 | 13.15 SEK |
1 purchase reported after at least 12 months of silence — most recent on 01 Apr 2022.